全文获取类型
收费全文 | 2350篇 |
免费 | 207篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 121篇 |
妇产科学 | 25篇 |
基础医学 | 280篇 |
口腔科学 | 112篇 |
临床医学 | 288篇 |
内科学 | 502篇 |
皮肤病学 | 31篇 |
神经病学 | 112篇 |
特种医学 | 215篇 |
外科学 | 281篇 |
综合类 | 49篇 |
一般理论 | 1篇 |
预防医学 | 249篇 |
眼科学 | 46篇 |
药学 | 139篇 |
中国医学 | 1篇 |
肿瘤学 | 132篇 |
出版年
2021年 | 28篇 |
2018年 | 41篇 |
2017年 | 26篇 |
2016年 | 24篇 |
2015年 | 53篇 |
2014年 | 43篇 |
2013年 | 66篇 |
2012年 | 60篇 |
2011年 | 61篇 |
2010年 | 62篇 |
2009年 | 67篇 |
2008年 | 49篇 |
2007年 | 78篇 |
2006年 | 88篇 |
2005年 | 91篇 |
2004年 | 77篇 |
2003年 | 51篇 |
2002年 | 69篇 |
2001年 | 65篇 |
2000年 | 69篇 |
1999年 | 81篇 |
1998年 | 62篇 |
1997年 | 64篇 |
1996年 | 69篇 |
1995年 | 51篇 |
1994年 | 56篇 |
1993年 | 52篇 |
1992年 | 53篇 |
1991年 | 50篇 |
1990年 | 51篇 |
1989年 | 61篇 |
1988年 | 75篇 |
1987年 | 54篇 |
1986年 | 46篇 |
1985年 | 57篇 |
1984年 | 36篇 |
1983年 | 23篇 |
1982年 | 27篇 |
1981年 | 23篇 |
1980年 | 22篇 |
1979年 | 30篇 |
1978年 | 26篇 |
1977年 | 24篇 |
1976年 | 31篇 |
1974年 | 19篇 |
1973年 | 23篇 |
1970年 | 18篇 |
1969年 | 21篇 |
1968年 | 19篇 |
1966年 | 23篇 |
排序方式: 共有2594条查询结果,搜索用时 15 毫秒
101.
102.
Louise Binder Majd Ghadban Christina Sit Kathleen Barnard 《Current oncology (Toronto, Ont.)》2022,29(3):1514
Public reimbursement systems face the challenge of balancing provision of needed treatments and the reality of limited resources. Canada has a complex system for drug approval and public reimbursement, with jurisdiction divided between the federal government and the provinces/territories. A pivotal role is that of health technology assessment (HTA), which relies primarily on health economic principles to analyze the value of drugs on a population health basis and make recommendations about public reimbursement. The Canadian Agency for Drugs and Technologies in Health (CADTH) provides recommendations to all provinces but Quebec. This article provides an overview of Canada’s approval and public reimbursement pathway, including the role of HTA and the economic principles on which it relies. Starting in late 2020, CADTH reduced the cost per quality-adjusted life year (QALY) threshold, the metric relied upon in making recommendations to public payers. An analysis of all 56 oncology drug final recommendations issued from January 2020 to January 2022 was conducted and confirms this reduction in the cost per QALY threshold. As a result of this threshold reduction, recommendations to the provinces include, in a number of cases, substantially greater price reductions. The potential implications for successful price negotiation with the pan-Canadian Pharmaceutical Alliance (pCPA), the public negotiating body for the provinces, are discussed. 相似文献
103.
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. 总被引:22,自引:0,他引:22 下载免费PDF全文
A D Michelson M R Barnard H B Hechtman H MacGregor R J Connolly J Loscalzo C R Valeri 《Proceedings of the National Academy of Sciences of the United States of America》1996,93(21):11877-11882
To examine the hypothesis that surface P-selectin-positive (degranulated) platelets are rapidly cleared from the circulation, we developed novel methods for tracking of platelets and measurement of platelet function in vivo. Washed platelets prepared from nonhuman primates (baboons) were labeled with PKH2 (a lipophilic fluorescent dye), thrombin-activated, washed, and reinfused into the same baboons. Three-color whole blood flow cytometry was used to simultaneously (i) identify platelets with a mAb directed against glycoprotein (GP)IIb-IIIa (integrin alpha 11b beta 3), (ii) distinguish infused platelets by their PKH2 fluorescence, and (iii) analyze platelet function with mAbs. Two hours after infusion of autologous thrombin-activated platelets (P-selectin-positive, PKH2-labeled), 95 +/- 1% (mean +/- SEM, n = 5) of the circulating PKH2-labeled platelets had become P-selectin-negative. Compared with platelets not activated with thrombin preinfusion, the recovery of these circulating PKH2-labeled, P-selectin-negative platelets was similar 24 h after infusion and only slightly less 48 h after infusion. The loss of platelet surface P-selectin was fully accounted for by a 67.1 +/- 16.7 ng/ml increase in the plasma concentration of soluble P-selectin. The circulating PKH2-labeled, P-selectin-negative platelets were still able to function in vivo, as determined by their (i) participation in platelet aggregates emerging from a bleeding time wound, (ii) binding to Dacron in an arteriovenous shunt, (iii) binding of mAb PAC1 (directed against the fibrinogen binding site on GPIIb-IIIa), and (iv) generation of procoagulant platelet-derived microparticles. In summary, (i) circulating degranulated platelets rapidly lose surface P-selectin to the plasma pool, but continue to circulate and function; and (ii) we have developed novel three-color whole blood flow cytometric methods for tracking of platelets and measurement of platelet function in vivo. 相似文献
104.
105.
G. M. Smith J. A. Child M. H. Cullen N. P. Bailey C. M. Woodruffe J. Fletcher H. Earl D. Barnard 《Hematological oncology》1996,14(4):193-201
In a multi-centre phase I study we investigated the possibility of reducing the interval between courses of standard CHOP (cyclophosphamide 750 mg/mdoxorubicin 50 mg/mvincristine 2 mgs day 1, and prednisolone 40 mg/m2 days 1–8) from 21 days to 15 days and then 10 days using granulocyte colony stimulating factor (r-MetHuG-CSF (Amgen)-filgrastim) to accelerate neutrophil recovery. Patients received CHOP followed by G-CSF 5 μg/kg s.c. from day 2 to the day before the next course (e.g. days 2–14 for the 15-day interval). A total of 28 patients with newly diagnosed intermediate grade or high grade NHL were studied. Four patients were studied at a 21-day interval, six patients were treated at a 15-day interval and subsequently six patients at a 10-day interval. Following analysis of this initial cohort, a further 12 patients were evaluated; four at the 15-day interval, and eight at the 10-day interval. No dose-limiting toxicity was seen in the four patients receiving 21-day CHOP. Dose-limiting toxicity was seen in 4/10 patients treated at the 15-day interval (M:F 7:3, median age 55·5, range 39–67 years). This consisted of infection in two patients, recurrent infection and debility in a third, and mucositis in a fourth. Seven patients experienced one or more infectious episodes requiring antibiotics (median number of episodes: 2, range 1–4). Fourteen patients (M:F 4:3, median age 47·5, range 25–63 years) were treated at the 10-day interval. Dose-limiting toxicity was seen in six patients. This consisted of severe mucositis in three patients, neutropenia and thrombocytopenia on two separate occasions in one patient, and steroid-induced gastritis in two patients. Nine patients had one or more documented infections (median: 2, range 1–3) requiring antibiotics, of which six were severe (WHO grade 3 or 4). One patient died of Pneumocystis carinii (PCP) pneumonia. In summary, G-CSF (filgrastim) will facilitate the shortening of the dosage interval between cycles of CHOP chemotherapy due to accelerated hematological recovery. However, non-hematological toxicity due to the shorter dosage interval is increased and infective episodes are frequent. © 1996 John Wiley & Sons, Ltd. 相似文献
106.
G. K. Poon P. Mistry F. I. Raynaud K. R. Harrap B. A. Murrer C. F. J. Barnard 《Journal of pharmaceutical and biomedical analysis》1995,13(12):1493-1498
The present study describes the application of on-line liquid chromatography-electrospray ionisation in conjunction with a high resolution magnetic sector mass spectrometer to identify metabolites of a platinum(IV) anticancer drug JM216 bis(acetato)amminedichloro(cyclohexylamine)platinum(IV)] in human plasma. Four metabolites were identified following incubation of JM216 in human plasma: JM118 [amminedichlorocyclohexylamineplatinum(II)], a platinum(II) complex; JM383 [bis(acetato)amminedihydroxo(cyclohexylamine)platinum(IV)]; JM518 [bis(acetato)amminechloro(cyclohexylamine)hydroxoplatinum(IV)] and its isomer JM559. The platinum complexes mass spectra were dominated by the natriated [M + Na]+ ion. Elemental compositions of these natriated ions were confirmed by accurate mass measurement on a magnetic sector mass spectrometer in the course of LC/MS analysis. This study demonstrates the capability of direct LC-ESI/MS with accurate mass measurement for analysis of platinum complexes in biological samples. Our results suggest that LC-ESI/MS is a powerful technique for structure elucidation of novel metabolites, and could make valuable contributions to drug metabolism research. 相似文献
107.
Abstract: The study of plasma integrates physics, chemistry, biology, and engineering, and has recently engaged medicine and dental hygiene in research efforts. The study of plasma holds promise for a myriad of applications ranging from lasers and electronics, hazardous waste management, decontamination, sterilization and disinfection of foods, soil, water, instruments, to medical uses in wound healing and treating certain types of tumours and cancers. Plasma represents a new state-of-the-art sterilization and disinfection treatment for certain oral and enviornmental pathogens, heat-sensitive materials, contaminated medical waste, hard and soft surfaces, and ventilation systems may assist health care facilities in the management of various health concerns. The role that Low Temperature Atmospheric Pressure Plasma (LTAPP) could play in the inactivation of pathogenic microorganisms might prove to be a new, faster, noncorrosive, more economical alternative, as well as support green healthcare. 相似文献
108.
Arthur W. Barnard Vera Sazonova Arend M. van der Zande Paul L. McEuen 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(47):19093-19096
We simulated the behavior of suspended carbon nanotube resonators over a broad range of temperatures to explore the physics of semiflexible polymers in underdamped environments. We find that thermal fluctuations induce strong coupling between resonance modes. This effect leads to spectral fluctuations that readily account for the experimentally observed quality factors Q ∼ 100 at 300 K. Using a mean-field approach to describe fluctuations, we analytically calculate Q and frequency shifts in tensioned and buckled carbon nanotubes and find excellent agreement with simulations. 相似文献
109.
110.